Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Breast Cancer Therapeutics Market
Breast Cancer Therapeutics Market Size
- Report ID: GMI466
- Published Date: Nov 2023
- Report Format: PDF
Breast Cancer Therapeutics Market Size
Breast Cancer Therapeutics Market size was around USD 26.7 billion in 2022 and is expected to reach USD 54.7 billion by 2032. The growing incidence of breast cancer is amongst the major factors stimulating the market growth.
According to the International Agency for Research on Cancer (WHO), in 2021, the incidence of breast cancer was more than 2.2 million, accounting for approximately 11.7% of the total cancer cases globally. Further, the disease accounted for 684,996 mortalities in 2020. Thus, the high incidence and mortality rate associated with breast cancer is expected to render significant impact, driving the market progress
Breast cancer therapeutics can be defined as the treatment or management of breast cancer using therapeutic approach & drugs such as chemotherapy, radiation therapy, hormone therapy, targeted therapy, and immunotherapy. These oncology drugs/therapeutics abduct the growth and multiplication of cancerous cells by disrupting certain proteins or DNA.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Breast Cancer Therapeutics Market Size in 2022: | USD 26.7 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 7.3% |
| 2032 Value Projection: | USD 54.7 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 90 |
| Tables, Charts & Figures: | 86 |
| Segments covered: | Therapy and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Breast Cancer Therapeutics Market Scope
